Zimmer Biomet Holdings Inc, founded in 1927 and headquartered in Warsaw, Indiana, is a leading global innovator in musculoskeletal healthcare. The company specializes in designing, manufacturing, and marketing orthopedic reconstructive products, including joint replacement implants and surgical instruments, focusing on improving patient outcomes in surgery.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Zimmer Biomet began issuing bonds in 2009, establishing a track record of raised capital to support its strategies and acquisitions. Notable issuances include a $1 billion bond sold in 2015, which was utilized to finance the merger with Biomet and streamline operations. Currently, Zimmer Biomet's bond yields are competitive within the healthcare sector, reflecting investor confidence despite industry challenges. The company’s bonds feature various maturities and interest rates, with recent news indicating a focus on sustainable financing options.